Great Point Partners, a Greenwich, CT-based healthcare investment firm, closed its latest growth buy-out fund, at $306m.
Great Point Partners III, L.P.’s Limited Partners include leading endowments, foundations, family offices, banks and pension funds. The investment professionals and CEO Advisory Board at Great Point made a significant personal commitment to GPP III, approximately 8% of GPP III’s committed capital.
GPP III will continue the firm’s strategy of investing in growing, profitable health care companies that are led by management teams focused on achieving accelerated and sustainable growth.
The fund has already made three investments (representing approximately 30% of committed capital), all in growing pharmaceutical services companies, a core area of focus for the Firm.
Founded in 2003 by Managing Directors Jeffrey R. Jay, M.D., and David Kroin, Great Point Partners is a health care investment firm, currently with approximately $1.8 billion of equity capital currently under management and 28 professionals, investing in the United States, Canada, and Western Europe.
The firm has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology enabled businesses.